Notably, these results were limited to the KRAS wild-type squamous cell carcinoma and adenocarcinoma, whereas in adenocarcinoma histotype the effect of epigenetic silencing of KEAP1 was also observed in the EGFR mutated subpopulation. This evidence concerns the gene KRAS and adenocarcinoma.